Patents by Inventor Markus Gude

Markus Gude has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090099228
    Abstract: The invention relates to novel pyrazolo-tetrahydropyridines compounds and their use as orexin receptor antagonists.
    Type: Application
    Filed: April 25, 2007
    Publication date: April 16, 2009
    Applicant: Actelion Pharmaceuticals Ltd.
    Inventors: Hamed Aissaoui, Christoph Boss, Markus Gude, Ralf Koberstein, Thierry Sifferlen
  • Publication number: 20080108638
    Abstract: The invention relates to 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives and their use as potent “chemoattractant receptor-homologous molecule expressed on Th2 cells” antagonists in the treatment of prostaglandin mediated diseases, to pharmaceutical compositions containing these derivatives and to processes for their preparation.
    Type: Application
    Filed: August 23, 2005
    Publication date: May 8, 2008
    Applicant: ACTELION PHARMACEUTICALS,LTD.
    Inventors: Heinz Fretz, Markus Gude, Kurt Hilpert, Julien Pothier, Markus Riederer, Matthias Steger
  • Patent number: 7019002
    Abstract: The invention provides pyrido[2,3-d]pyrimidin-7(8H)-one telomerase inhibitors of the formula where R1, R2 are as defined herein. The invention also provides methods for preparing the compounds of formula I, methods of using the compounds to treat diseases such as cancer, and pharmaceutical compositions comprising the compounds.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: March 28, 2006
    Assignee: Pharmacia & Upjohn, S.p.A.
    Inventors: Mauro Angiolini, Dario Ballinari, Domenico Fusar Bassini, Luisella Bonomini, Markus Gude, Maria Menichincheri, Jurgen Moll, Jean-Yves Trosset
  • Publication number: 20040132807
    Abstract: The present invention relates to know and novel substituted aurones active as telomerase inhibitors, to their use as therapeutic agents, in particular as antitumoral agents, to a process for their preparation as to pharmaceutical compositions comprising them.
    Type: Application
    Filed: October 17, 2003
    Publication date: July 8, 2004
    Inventors: Dario Ballinari, Luisella Bonomini, Antonella Ermoli, Markus Gude, Maria Menichincheri, Jurgen Moll, Ermes Vanotti
  • Publication number: 20040009993
    Abstract: The invention provides novel pyrido[2,3-d]pyrimidin-7(8H)-ones derivatives active as telomerase inhibitors, the use of the derivatives as therapeutic agents, such as antitumoral agents, processes for preparation of the derivatives, and to pharmaceutical compositions comprising the derivatives.
    Type: Application
    Filed: December 4, 2002
    Publication date: January 15, 2004
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Mauro Angiolini, Dario Ballinari, Domenico Fusar Bassini, Luisella Bonomini, Markus Gude, Maria Menichincheri, Jurgen Moll, Jean-Yves Trosset